April 26th, 2013 (InsideCostaRica.com) Costa Rica’s national health system (CCSS or “Caja”) will finish pulling from its pharmacy shelves this week two medications because of manufacturing defects and adverse side affects.
The first drug to be pulled is the injectable Diclofenac, used for the treatment of pain and inflammation, manufactured by Biosano Laboratories in Chile. The first adverse reactions from the drug began being reported in October 2012.
Tests revealed that the compound contained a substance commonly used as a solvent.
The CCSS says there are suitable alternatives for the drug on their pharmacy shelves.
The second drug is Promethazine 25, used to treat motion sickness, nausea, and vomiting amongst other uses.
Tests reveal that the drug contains a crystalline precipitate that could result in the “failure” of the drug and adverse reactions. CCSS said there are also suitable substitutes for Promethazine on their pharmacy shelves.
The CCSS is recommending that anyone who has these drugs at home return them to CCSS pharmacies or clinics.